Talk to an advisor : +9714 335 3839 Email: Info@viviscal.ae

Talk to a Customer Service: +9714 335 3839 Email: Info@viviscal.ae

Clinical Studies

Re-iterative Research to Reproduce Results.

THE CLINICAL TRIALS PROCESS

2012 (15 Female)

Glynis Ablon, M.D., FAAD, Ablon Skin Institute Research Center, University of California, Los Angeles, California, U.S.A.

6-month double-blind, placebo-controlled clinical trial demonstrated statistically significant results:

125% increase in terminal hairs vs. placebo group Significant, self-perceived improvements in overall hair volume, thickness and scalp coverage Published: The Journal of Clinical and Aesthetic Dermatology (Nov. 2012)


2013 (72 females)

Thomas J. Stephens & Associates, Inc., Dallas Research Center, Carrollton, Texas, U.S.A.

6-month double-blind, placebo-controlled clinical trial demonstrated statistically significant results:

18.3% reduction in hair shedding vs. placebo 7.4% increase in hair thickness vs. placebo

Abstract presented: 7th World Congress for Hair Research (2013; Edinburgh, Scotland)


2014 (40 females)

Glynis Ablon, M.D., FAAD, Ablon Skin Institute Research Center, University of California, Los Angeles, California, U.S.A.; and Steven Dayan, M.D., FACS, DeNova Research, Chicago, Illinois, U.S.A.

(In progress) 6-month, multi-center, randomized, double-blind, placebo-controlled clinical trial

Hypothesis: ingestion of oral Viviscal supplement will strengthen and promote terminal hairs in female subjects, ages 21-75, who have self-perceived thinning hair

Estimated publication date: summer 2015

FREE SHIPPING

Free shipping for all UAE orders

SUPPORT 24/7

24x7 customer and billing support

30 DAYS RETURN

30 days return policy on products*

SECURED ONLINE PAYMENTS

100% Secured payment modes

Connect With Us

Send A Message

Send Now

Mini Cart

Cart is Empty